- Home
- Companies
- micronesia
- in vitro study
Refine by
In Vitro Study Suppliers Near Micronesia
65 companies found
based inRio Grande, NEW JERSEY (USA)
We deliver wound therapies for superior outcomes. AediCell provides safe, effective, and easy to use products at a lower overall cost. Aedicell® is a regenerative medicine company that has developed a unique proprietary process to transform human ...
The only product on the market that combines human tissue sourced from the amniotic/chorionic membrane, umbilical cord AND placental disc —Dermavest®. This combination delivers a myriad of cell attachment proteins (CAP) including collagen, ...
based inDerio, SPAIN
Innoprot is a company specializing in the development and provision of high-quality cell lines and assays for use in research and drug discovery. They offer a wide array of G protein-coupled receptor (GPCR) cell lines, which are essential for ...
based inGuildford, UNITED KINGDOM
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys technology. Futura Medical is an innovative R&D company with a pipeline of products in late stage development. ...
Scientific advisory meeting held with MHRA confirming the need of a Phase 3 study to support the improved skin permeation including potential superior efficacy claims. Exploring the feasibility of a clinical study to satisfy the Phase 3 requirements ...
based inCarasco, ITALY
Mectron has been active and successful in the dental field since 1979, developing and producing top-quality devices. The company has always stood out on the market for its continuous process of development and innovation and the excellent design of ...
When mectron introduced PIEZOSURGERY® in 2001, the technology was revolutionary for bone surgery: a device which provided precision, safety, perfect ergonomics and the highest quality to surgeons all around the world. Soon the new technology ...
based inMontreal, QUEBEC (CANADA)
SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary ...
based inNorth Ryde, AUSTRALIA
Biotron Limited (Biotron) is a clinical stage publicly listed Australian Biotechnology Company based in Sydney, Australia. The company is developing and commercialising a novel small molecule approach that has the potential to treat a number of ...
Biotron is developing novel small molecule antiviral therapeutics targeting a range of viruses including Hepatitis C virus (HCV) and ...
based inMontreal, QUEBEC (CANADA)
eNUVIO three founders first met as graduate students in 2010, working together on an interdisciplinary collaboration between two university science labs in Montreal. At that time, it was obvious that they shared a strong interest for research tool ...
Get even more out of your neuronal cultures and co-cultures with the latest in microfluidic devices from eNUVIO. OMEGAACE devices can be used for in vitro triple co-culture studies of neurodegeneration, ...
based inHudson, MASSACHUSETTS (USA)
Proveris Scientific specializes in providing advanced instrument and laboratory services for testing solutions in the development and manufacturing of oral inhalation and nasal drug products (OINDP). They are recognized globally for their expertise ...
based inIrvine, CALIFORNIA (USA)
Biogennix is a leading developer of advanced osteobiologic products specifically designed for orthopedic and spine surgery. Founded in 2009, we are led by a team of scientists and industry veterans committed to delivering innovative products for ...
One of the primary functions of a bone graft material is to provide an osteoconductive surface for new bone formation. Bone regeneration is a cellular process that involves the interaction of osteoblasts and stem cells with the surface of a ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
TP-0184 is an investigational inhibitor of activin receptor-like kinase 2 (ALK2) and ALK5 (also known as TGFβR1). This bimodal inhibitor is believed to downregulate multiple TGF-β superfamily signaling pathways and has shown antitumor ...
based inNess Ziona, ISRAEL
BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic ...
We are developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa (P. aeruginosa) respiratory infections, a main contributor to morbidity and mortality in this disease. Phase 1b/2a clinical study in CF patients is composed ...
based inFlorham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
We are developing CYNK-101 as a combination treatment for multiple cancer indications. CYNK-101 is manufactured from a specific type of immune cell, NK cells, that we extract from postpartum placentas and then genetically engineer to increase cell ...
based inShanghai, CHINA
Bioventus LLC is a medical technology company that specializes in the development and distribution of orthobiologic solutions designed to support bone healing and regeneration. The company is known for its registered trademarks such as OSTEOAMP, ...
OSTEOAMP is backed by science to meet the surgeon's need for a proven allograft that can achieve solid fusion ...
based inCottesloe, AUSTRALIA
Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need. Our vision ...
EmtinB is the lead candidate that has shown to closely mimic the neuroprotective and neuroregenerative ability of MT-II. ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
The XF drug platform has a novel, ultra-rapid mechanism that reduces the chance of bacteria becoming resistant to its action. Destiny Pharma’s XF platform has advantages over traditional antibiotics. ...
based inLodi, WISCONSIN (USA)
Attwill develops and manufactures pharmaceuticals, medical devices, and biologics in the heart of Wisconsin. Attwill’s scalable production and funding solutions are well equipped to take new ideas from startup to scale. With lyophilization at ...
FILTERGuard™ is a disposable IV filter with CHG. The sterile, single-use disposable IV filter is infused with chlorhexidine gluconate (CHG) to help reduce the incidence of bloodstream infections, local infections and skin colonization in ...
based inCorona, CALIFORNIA (USA)
For over 20 years, United Endoscopy has been a leader in providing state-of-the-art refurbished medical equipment and advanced equipment repair to its customers worldwide. Since its founding in 1996 by Jeremy Cooper, United Endoscopy has ...
based inLargo, FLORIDA (USA)
CONMED is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical ...
With strong fixation, less bone removal and a simple, self-punching technique, the Y-Knot® RC helps overcome the trade-offs of other rotator cuff fixation methods. The first self-punching all-suture anchor available, Y-Knot® RC anchors can ...
based inBozeman, MONTANA (USA)
Microbion is a clinical-stage pharmaceutical company developing a novel class of compounds for the treatment of difficult-to-treat infections, including chronic infections and antibiotic-resistant infections. Microbion is dedicated to developing ...
Microbion has two Phase 2 clinical programs in diabetic foot ulcer infection and orthopedic implant infection. In addition, preclinical programs are under development for multiple therapeutic indications, including the treatment of serious ...
based inParamus, NEW JERSEY (USA)
Regenity Biosciences is a trusted partner in regenerative medicine. Founded in 1997, Regenity is a trailblazer in soft and hard tissue regeneration. We bring curiosity, scientific rigor, and a sense of urgency to creating transformative medical and ...
A sponge-like onlay with a leak resistant top layer that provides effective protection against CSF leakage. When hydrated, this highly drapeable matrix is easily repositionable and conforms to the complex surfaces of the brain or spinal cord. The ...